Nkarta (NKTX) Long-Term Investments (2023 - 2026)
Nkarta (NKTX) posted quarterly Long-Term Investments of $33.6 million for Q1 2026, down 59.87% year-over-year from $83.7 million in Q1 2025, and up 108.41% quarter-over-quarter from $16.1 million in Q4 2025.
Nkarta (NKTX) Long-Term Investments (2023 - 2026) Analysis & Trends
Nkarta's Long-Term Investments history runs 4 years deep, the most recent figure standing at $33.6 million for Q1 2026.
- In Q1 2026, Long-Term Investments fell 59.87% year-over-year to $33.6 million; the TTM figure through Mar 2026 stood at $33.6 million (down 59.87% YoY), while the FY2025 annual figure was $16.1 million, down 85.41% from the prior year.
- Long-Term Investments for Q1 2026 stood at $33.6 million, up from $16.1 million in the prior quarter.
- The five-year high for Long-Term Investments was $119.5 million in Q3 2024, with the low at $6.0 million in Q1 2023.
- The 4-year median for Long-Term Investments is $33.6 million (2026), against an average of $51.8 million.
- Peak annual rise in Long-Term Investments reached 752.36% in 2025, while the deepest fall reached 85.41% in 2025.
- Nkarta's Long-Term Investments stood at $18.7 million in 2023, then surged by 489.45% to $110.4 million in 2024, then slumped by 85.41% to $16.1 million in 2025, then jumped by 108.41% to $33.6 million in 2026.
- Business Quant data shows NKTX's Long-Term Investments at $33.6 million in Q1 2026, $16.1 million in Q4 2025, and $31.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - | 57.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.67 Mn |
| Mar 31, 2026 | 33.57 Mn |
| Dec 31, 2025 | 16.11 Mn |
| Sep 30, 2025 | 31.42 Mn |
| Jun 30, 2025 | 41.61 Mn |
| Mar 31, 2025 | 83.65 Mn |
| Dec 31, 2024 | 110.39 Mn |
| Sep 30, 2024 | 119.47 Mn |
| Jun 30, 2024 | 99.09 Mn |
| Mar 31, 2024 | 9.81 Mn |
| Jun 30, 2023 | 18.73 Mn |
| Mar 31, 2023 | 6.02 Mn |